Insider Sale at Cocrystal Pharma (COCP) Deemed Significant
10:20 PM EDT, 05/07/2021 (MT Newswires) -- An insider disposed of 575,000 shares of Cocrystal Pharma having a market value of approximately $1,696,250 today, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.
Relative to its peers over the last 90 days, insider buy/sell trading at Cocrystal Pharma is greater than the 20-company peer group average. Generic Pharmaceuticals peer group saw 1 buy/sell trades during this period for an average of 0.1 transactions per company. The number of shares per buy/sell trade for Cocrystal Pharma insiders was also higher. Within the peer group there were 0 shares purchased and 17,290 shares sold with company insiders selling 17,290 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in creating and writing this story.
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.